These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7175732)

  • 21. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic studies of theophylline in cats.
    McKiernan BC; Koritz GD; Davis LE; Neff-Davis CA; Pheris DR
    J Vet Pharmacol Ther; 1983 Jun; 6(2):99-104. PubMed ID: 6887346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.
    Upton RA; Sansom L; Guentert TW; Powell JR; Thiercelin JF; Shah VP; Coates PE; Riegelman S
    J Pharmacokinet Biopharm; 1980 Jun; 8(3):229-42. PubMed ID: 7420268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of theophylline following a rectally administered concentrated aminophylline solution.
    Mason WD; Lanman RC; Amick EN; Arnold J; March L
    J Allergy Clin Immunol; 1980 Aug; 66(2):119-22. PubMed ID: 7400475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
    Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
    J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent absorption of theophylline in man.
    Watanabe H; Nakano S; Nagai K; Ogawa N
    J Clin Pharmacol; 1984; 24(11-12):509-14. PubMed ID: 6511990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacolinetic and pharmacodynamic data analysis of theophylline for three different drug forms.
    Richter O; Reinhardt D; Appel R
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):479-89. PubMed ID: 6271690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of Theodel, a new theophylline tablet, in humans.
    Rovei V; Strolin Benedetti M; Donath A; Grenot C; Chanoine F
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):425-30. PubMed ID: 6629546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
    Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
    Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline.
    Van Aerde P; Moerman E; Van Severen R; Braeckman P
    Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theophylline bioavailability following oral administration of six sustained-release preparations.
    Spangler DL; Kalof DD; Bloom FL; Wittig HJ
    Ann Allergy; 1978 Jan; 40(1):6-11. PubMed ID: 623398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
    J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The absolute bioavailability of oral theophylline in patients with spinal cord injury.
    Segal JL; Brunnemann SR; Gordon SK; Eltorai IM
    Pharmacotherapy; 1986; 6(1):26-9. PubMed ID: 3952003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and relative bioavailability of oral theophylline capsules.
    Lesko LJ; Canada AT; Eastwood G; Walker D; Brousseau DR
    J Pharm Sci; 1979 Nov; 68(11):1392-4. PubMed ID: 583162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.